Back
EHRA Premium Access

Risk of progression to malignant ventricular arrhythmia's in carriers of the cardiomyopathy causing (PLN) p.Arg14del mutation

Session: Moderated ePosters 8: channelopathies & cardiomyopathies
Topic: Other Genetic Variants
Speaker: Mr T. Verstraelen (Amsterdam, NL)
Event: EHRA 2019

Congress Presentation

Add to my library

Like

About the speaker

Mr Tom Verstraelen

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

7 more presentations in this session

Ethnical differences in patients with brugada syndrome and arrhythmic events: new insights from sabrus

Speaker: Doctor A. Milman (Tel Hashomer, IL)

Access
Abstract
Slides
Like
Thumbnail

Genotype-phenotype correlations in patients with arrhythmogenic cardiomyopathy: results from next generation sequencing in a large multicenter cohort

Speaker: Assistant Professor A. Saguner (Zurich, CH)

Access
Abstract
Like
Thumbnail

Safety of general anesthesia in brugada syndrome

Speaker: Doctor G. Ciconte (San Donato Milanese, IT)

Access
Abstract
Slides
Like
Thumbnail

Prognostic implications of non-sustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathy

Speaker: Doctor C. Adduci (Rome, IT)

Access
Abstract
Like
Thumbnail

Large repolarization gradients increase susceptibility to trigger-induced arrhythmias and are not reflected by QT time

Speaker: Doctor M. Cluitmans (Maastricht, NL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Moderated ePosters 8: channelopathies & cardiomyopathies

Speakers: Mr T. Verstraelen, Doctor A. Milman, Assistant Professor A. Saguner, Doctor G. Ciconte, Doctor C. Adduci...
Access
Like
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources